IL10 and acute respiratory distress syndrome: In a lipopolysaccharide (LPS)-induced ALI mouse model, IL-10/sLNP demonstrated both prophylactic and therapeutic efficacy, significantly attenuating pulmonary and systemic inflammation, restoring barrier integrity, and reducing tissue injury.